With a strong trial and appellate litigation practice, Blake, Cassels & Graydon LLP have a proven track record in patent, regulatory, trademark and copyright issues. The group is co-led by experienced partners Fiona Legere, who is a key contact for clients in the life sciences, telecom and tech industries; and Geoff Mowatt, who has a strong emphasis on patent litigation in the pharmaceutical, chemical and biotech industries. The team has been strengthened by two new counsel in the last year: Rebecca Crane joined in April 2026 from Markwell Clarizio LLP, and Stephanie Anderson joined from Belmore Neidrauer LLP in October 2025. All named lawyers work in Toronto.
Legal 500 Editorial commentary

Key clients

  • Sharda Cropchem
  • Janssen and BTG International
  • Regeneron Pharmaceuticals and Bayer Aktiengesellschaft
  • Norco Bicycles (LTP Sports Group)
  • Novo Nordisk
  • Strathcona Resources
  • Bell Canada and Bell Media
  • EMD Serono and Merck Serono
  • Wescam/ L3 Harris
  • Masters Best Friend
  • MedSpa Partners
  • Merck & Co.

Work highlights

Co-leading Janssen and Janssen Pharmaceutica in an appeal before the SCC pertaining to Janssen's Invega Sustenna product - a treatment for schizophrenia and related disorders.
Representing Bell on a copyright infringement and anti-competition lawsuit against its Canadian rival TELUS.
Representing EMD Serono and Merck Serono in two PMNOC patent litigation actions involving the drug MAVENCLAD® (cladribine) for the treatment of multiple sclerosis.

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

Fiona Legere; Geoff Mowatt

Other key lawyers

Rebecca Crane; Stephanie Anderson